Viaca combination for erectile function
Treatments studied
Part of Kidney & urinary, Mental health clinical trials.
This study tests a new combination pill (Viaca) that includes two medicines for erectile dysfunction. It will see if the combination is safe and how it works in healthy men. If you are a man aged 18 to 65 in good health, this trial may help advance treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a man between 18 and 65 years old.
- You should be in good health with no major medical conditions like heart disease, high blood pressure, or diabetes.
- Your blood pressure must be within a normal range (110–140 mmHg systolic).
- Your body mass index (BMI) must be between 18 and 32.
- You should not smoke regularly or use tobacco for at least 2 months before screening.
- You must agree to use contraception and not donate sperm for 90 days after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking one Cialis pill daily and a Viagra pill only when needed works better for men who have tried ED pills before but they didn't help. It aims to find a new way to help men who haven't responded to standard ED treatments.
This study tests a new medicine, W2505, to see if it is safe and effective for men with erectile dysfunction. Participation may help you manage your condition and contribute to research.
This study tests a new form of sildenafil (the active ingredient in Viagra) for treating erectile dysfunction in men. It aims to see how well it works and how safe it is, and you'll need to track your progress using a smartphone app.
This study tests two different ways to treat erectile dysfunction (ED): a combination of two commonly used medications (tadalafil and sildenafil) versus a single medication (tadalafil). It aims to see which approach works better and is safe for men with ED.
This early-phase trial tests VV913 capsules in healthy men to see how safe they are and how the body processes the drug. It may help find the right dose for future studies.
This study tests an investigational capsule, VV913, to see if it can help men with premature ejaculation last longer during sex. If you qualify, you may receive the study drug or a placebo (inactive capsule) and will be closely monitored.
Hear when a new Erectile Dysfunctions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.